AWS introduced Amazon Bio Discovery, an AI platform to speed early-stage drug development by enabling code-free computational workflows.
The tool’s model library and AI agent can cut an 18‑month, 300‑candidate pipeline to weeks, VP Rajiv Chopra said.
Early adopters include Bayer, the Broad Institute and Voyager Therapeutics, and AWS serves 19 of the top 20 pharma firms.